These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Chubb SA; Davis WA; Inman Z; Davis TM Clin Endocrinol (Oxf); 2005 Apr; 62(4):480-6. PubMed ID: 15807880 [TBL] [Abstract][Full Text] [Related]
5. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Celani MF; Bonati ME; Stucci N Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793 [TBL] [Abstract][Full Text] [Related]
7. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the relationship between subclinical hypothyroidism and metabolic syndrome components among workers. Cheserek MJ; Wu G; Shen L; Shi Y; Le G Int J Occup Med Environ Health; 2014 Apr; 27(2):175-87. PubMed ID: 24619737 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Bindels AJ; Westendorp RG; Frölich M; Seidell JC; Blokstra A; Smelt AH Clin Endocrinol (Oxf); 1999 Feb; 50(2):217-20. PubMed ID: 10396365 [TBL] [Abstract][Full Text] [Related]
11. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864 [TBL] [Abstract][Full Text] [Related]
13. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Tanis BC; Westendorp GJ; Smelt HM Clin Endocrinol (Oxf); 1996 Jun; 44(6):643-9. PubMed ID: 8759176 [TBL] [Abstract][Full Text] [Related]
14. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Danese MD; Ladenson PW; Meinert CL; Powe NR J Clin Endocrinol Metab; 2000 Sep; 85(9):2993-3001. PubMed ID: 10999775 [TBL] [Abstract][Full Text] [Related]
15. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. Iqbal A; Jorde R; Figenschau Y J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of hypothyroidism in patients with dyslipidemia: Tehran Thyroid Study (TTS). Khazan M; Amouzegar A; Gharibzadeh S; Mehran L; Tohidi M; Azizi F Horm Metab Res; 2014 Dec; 46(13):980-4. PubMed ID: 25369072 [TBL] [Abstract][Full Text] [Related]
17. Subclinical hypothyroidism in childhood obesity and its correlation with lipoproteins. Emokpae MA; Adeleke SI; Uwumarongie HO Afr J Med Med Sci; 2011 Dec; 40(4):361-5. PubMed ID: 22783686 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arem R; Patsch W Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095 [TBL] [Abstract][Full Text] [Related]
19. Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study. Zhao M; Yang T; Chen L; Tang X; Guan Q; Zhang B; Zhang X; Zhang H; Wang C; Xu J; Hou X; Li Q; Yu C; Zhao Y; Fang L; Yuan Z; Xue F; Ning G; Gao L; Xu C; Zhao J Thyroid; 2015 May; 25(5):485-93. PubMed ID: 25780934 [TBL] [Abstract][Full Text] [Related]
20. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]